Drug · DIN 02224828
RYTHMODAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since May 24, 2012; first marketed September 15, 2003.
- Drug Identification Number (DIN)
- 02224828
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Disopyramide C01BA03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DISOPYRAMIDE | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 4, 2006: NOC 7928New Drug Submission (NDS) · Manufacturer name change
- July 21, 2000: NOC 1101New Drug Submission (NDS)
Other DINs named RYTHMODAN
- DIN 02224801 · Dormant